A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus.

Ther Adv Chronic Dis · 2021 · PMC8512260 · PMID 34729154

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The B-cell counts showed a trend of negative correlation with PLT levels; B-cell counts reflect the B-cell depletion effectiveness of RTX.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.